The synthesis of nine new quinazoline derivatives (2a-2i) and evaluation of their antimicrobial and cytotoxic activities were aims of the present work. For the synthesis of the compounds, 2-chloro-6,7-dimethoxyquinazolin-4-amine was used as the initial starting material. The intermediate product, 2-hydrazinyl-6,7-dimethoxyquinazolin-4-amine, was reacted with appropriate aromatic aldehydes to obtain 2-(2-benzylidenehydrazinyl)-6,7-dimethoxyquinazolin-4-amine derivatives as final compounds. The structures of the compounds were elucidated by 1 H-and 13 C-NMR, IR, and MS analyses. The new pure compounds were evaluated for their potential antimicrobial and cytotoxic activities using in vitro microdilution and cell culture techniques, respectively. The compounds 2e and 2f may be promising candidates for the treatment of fungal infections with their activity and cytotoxicity.
The treatment of bacterial and fungal infections still remains a major challenge due to the ability of microorganisms to develop resistance towards antimicrobial agents through various mechanisms. In order to overcome this problem, medicinal chemists have focused on the discovery of new potential antimicrobial agents, which either inhibit the growth of pathogens or eliminate them [1] . As known, not only biochemical similarity of the human cell and fungi forms is a handicap for selective activity, but also the aquainted resistance is the main problem encountered in developing safe and effective antifungals [2] .
Quinazoline is an important building block of naturally occurring alkaloids, which is utilized as a druglike scaffold in several natural products such as tryptoquivaline, circumdatin-F and -G, tryptanthrine, dipegine, dipeginol, vasicinone, deoxyvasicinone, rutaecarpine, and luotonin A [3] [4] [5] [6] [7] [8] . It is reported that more than 160 naturally occurring quinazolines have been isolated from different organisms including plants, animals and microorganisms [3] . The natural quinazolines and their synthetic analogs possess a variety of biological activities including antitumor [9] , anticonvulsant [10] , antiviral [11] , antiinflammatory [12] , analgesic [13] , antimicrobial [14] , antimalarial [15] , antidiabetic [16] , and cytotoxic [17] among others.
On the other hand, natural products that contain a nitrogen-nitrogen (N−N) bond constitute a group of compounds with a vast structural diversity. The review of LaRue published in 1977, summarized the isolation and biological activity of these compounds [18] . In the years since, many new members from several different structural classes have emerged. The recent review of Lachlan from 2013, compiles the new studies in this field. A comprehensive evaluation of the natural product literature has revealed more than 200 natural products containing an N-N bond [19] . Based on the natural importance and as part of our ongoing interest in the design and synthesis of novel heterocycles as antimicrobial agents, we have synthesized quinazoline hybrids including the N−N bond as a hydrazone moiety. Herein, we describe the synthesis of a novel series of quinazoline derivatives and focus attention on their potential antimicrobial activity and cytotoxicity with respect to WS-1 cell lines.
The synthesis of 6,7-dimethoxy-2-(2-benzylidenehydrazinyl)-quinazolin-4-amine derivatives (2a-2i) was carried out according to the steps shown in Scheme 1. In the initial step, 2-hydrazinyl-6,7-dimethoxyquinazolin-4-amine (1) was synthesized via the reaction of 2-chloro-6,7-dimethoxyquinazolin-4-amine with hydrazine. The treatment of the amine (1) with aromatic aldehyde gave compounds 2a-2i. In the 1 H NMR spectra of the compounds, NH 2 and also N-H protons appeared as two singlet peaks at δ 12.2-11.8 ppm (two peaks) and δ 8.5-9.1 (two peaks) in accordance with the presence of the E and Z isomers. The N=CH proton was observed at δ 8.2 as a singlet. All the aromatic protons were recorded at δ 6. protons of quinazolines appeared at δ 7.5-7.6 and 7.8-7.9 as singlets. Protons of two methoxy groups were observed at δ 3.8-4.0 as a two singlet peaks. 13 C NMR (APT) spectra gave the expected data for all the carbons of the target compounds.
Compound 2d exhibited the same antibacterial potency against Staphylococcus aureus, but none of the compounds showed high activity against Enterococcus faecalis 29212, although compounds 2c, 2d and 2i exhibited the same antibacterial potency against E. faecalis 51922. Moreover, the MIC value (25 µg/mL) of compound 2b was four-fold higher than that of chloramphenicol (0.1 mg/mL) against L. monocytogenes and compounds 2d, 2f and 2i showed the same activity as chloramphenicol. Only compound 2i exhibited the same activity against Klebsiella pneumonia and Pseudomonas aeruginosa, while none of the compounds showed comparable activity with chloramphenicol against Escherichia coli ATCC 25923, but compounds 2b, 2d, 2h and 2i displayed the same activity against E. coli ATCC 35218 ( Table 1) .
None of the compounds showed a valuable anticandidal effect against Candida krusei and C. parapsilopsis. However, compounds 2d and 2h were found to be twice as active as the standard drug whereas compounds 2b and 2g showed equipotent activity against C. albicans. Compound 2f exhibited the highest activity against C. glabrata with a MIC value of 100 µg/mL, which is twofold that of the standard drug's MIC value, whereas compounds 2b, 2c, 2d, 2g, 2h, and 2i showed the same activity as ketoconazole (Table 2) . One of the important criteria for an active agent is to have minimum or no side-effects on normal cells. According to the results of the antimicrobial activity tests, 2e was found to be a promising compound because its IC 50 value against the WS1 cell line was higher than its active concentrations in the antimicrobial activity tests. Also, the IC 50 value of 2f was found to be higher than its active concentrations against L. monocytogenes ATCC 1911 and C. glabrata ATCC 90030. However, the IC 50 values of the other compounds were found to be higher than their active concentrations. In conclusion, 2e and 2f did not show any cytotoxicity against WS1 cells at concentrations that showed antimicrobial effects. Therefore, these compounds may be promising candidates for the treatment of fungal infections. Concerning structure activity relationships, substitution on the benzylidene moiety may affect the activity of the compounds.
Experimental
General: All chemicals were purchased from commercial suppliers and used without purification. Melting points were determined on an Electrothermal 9100 digital melting point apparatus and were uncorrected. IR spectra were recorded on a Shimadzu 80,4S spectrophotometer, 1 H and 13 C NMR (APT) spectra on a Bruker 500 MHz spectrometer, and mass spectra on a MS-FAB VG Quattro Mass spectrometer.
Preparation of 2-hydrazinyl-6,7-dimethoxyquinazolin-4-amine (1): A mixture of 2-chloro-6,7-dimethoxyquinazolin-4-amine (0.02 mol) and hydrazine (2 mL) in ethanol was stirred at room temperature for 3 h and filtered. The residue was crystallized from ethanol [21] . 
6,7-Dimethoxy-2-[2-(4-methylbenzylidene)hydrazinyl]-quinazolin-4-amine (2b)
Yield
Antimicrobial activity:
The study was designed to compare MICs obtained by the CLSI reference M7-A7 broth microdilution method [20] . MIC readings were performed twice for each chemical agent. Tables 1 and 2 . Chloramphenicol and ketoconazole were used as standard reference compounds [20] .
Cytotoxicity test:
The human skin fibroblast cell line (WS1, ATCC ® CRL-1502™) was used for the cytotoxicity tests. The cell line was incubated in EMEM (Wisent Bioproducts, Canada) supplemented with 10% fetal bovine serum (Hyclone, Thermo Scientific, USA), 100 IU/mL penicillin and 100 mg/mL streptomycin (Hyclone, Thermo Scientific, USA) at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . WS1 cells were seeded at 1 x 10 4 cells into each well of 96-well plates. After 24 h of incubation, the culture media were removed and the compound was added to the culture medium at 3.9-500 µg/mL concentrations. After 24 h of incubation, cytotoxicity tests were performed using the MTT assay. Firstly, 20 μL MTT solution (5 mg/mL MTT powder in PBS) was added to each well. After a 3 h incubation period at 37 o C in 5% CO 2 , the contents of the wells were removed and 100 μL dimethyl sulfoxide (DMSO) was added to each well. Then, the OD of the plate was read at 540 nm. Inhibition % was calculated for each concentration of the compounds and IC 50 values were estimated by non-linear regression analysis. Stock solutions of compounds were prepared in dimethyl sulfoxide (DMSO) and further dilutions were made with fresh culture medium. The final DMSO concentration was under 0.1%. All experiments were performed in triplicate [21] .
